Company profile

AAX Biotech AB

Leveraging science and innovation to accelerate the development of next-generation antibody therapeutics.

Industry
Biotechnology Research
Employees
11
Headquarters
Stockholm, Stockholm County
LinkedIn followers
2,642
Office locations
1

AAX Biotech AB company summary

AAX Biotech AB is a company in the Biotechnology Research industry, headquartered in Stockholm, Stockholm County. On LinkedIn the company has around 11 employees and 2,642 followers. Its listed specialties include biotech, antibody therapeutics, next-generation antibody therapeutics, antibody-based medicines, drug development.

What technology does AAX Biotech AB use?

No technologies detected yet. Warmrank rechecks company websites on a rolling basis.

About AAX Biotech AB

AAX Biotech AB is a biotech company spun out from Karolinska Institutet by co-founders Mats AA Persson and Daniel X Johansson. We specialize in next-generation antibody therapeutics through our two unique and proprietary technologies, Seqitope™ and Opti-mAb™, that enable high-resolution and high throughput epitope mapping as well as stabilization of single chain variable fragments (scFv) for applications such as bispecific antibodies and CAR-T cells. Our team is made up of highly qualified experts, all with PhDs in relevant fields. Our mission is to innovate and solve unmet needs in antibody-based medicine development. We aim to be a leading partner for the global biopharmaceutical industry focusing on a broad range of diseases including cancer, autoimmune disorders, and neurological conditions. We are committed to providing unparalleled expertise and innovative technologies that contribute to the advancement of novel antibody therapeutics. Technologies: Seqitope™ is a high-resolution, high throughput method for antibody epitope mapping that accelerates the development of efficacious therapeutics. Opti-mAb™ is a new scFv format with dramatically improved expression levels and reduced aggregation tendencies. This will significantly improve the next generation of cutting-edge immunotherapies such as CAR-T and bispecific antibodies.

Specialties

biotechantibody therapeuticsnext-generation antibody therapeuticsantibody-based medicinesdrug developmentcancer therapyautoimmune diseasesneurological diseasesbig pharmabiopharmaceutical industry

Where is AAX Biotech AB located?

AAX Biotech AB lists 1 location.

Stockholm, Stockholm County, SEHQ
Visionsgatan 18

Compare companies similar to AAX Biotech AB

More companies in Biotechnology Research.

CompanyIndustryEmployeesFoundedHeadquarters
AAX Biotech AB
aaxbiotech.com
Biotechnology Research11-Stockholm, Stockholm County
Thermo Fisher Scientific
thermofisher.com
Biotechnology Research100,779-Waltham, MA
Amgen
amgen.com
Biotechnology Research41,0281980Thousand Oaks, CA
Biogen
biogen.com
Biotechnology Research7,742-Cambridge, MA
Biocon
biocon.com
Biotechnology Research11,902-Bangalore, Karnataka
Biotechnology Research28,679-Bethesda, MD
Genentech
gene.com
Biotechnology Research18,2961976South San Francisco, California
Eurofins
eurofins.com
Biotechnology Research24,928-Luxembourg, Luxembourg
Gilead Sciences
gilead.com
Biotechnology Research14,743-Foster City, CA
Syneos Health
syneoshealth.com
Biotechnology Research23,772-Morrisville, NC
Moderna
modernatx.com
Biotechnology Research6,2382010Cambridge, Massachusetts

Frequently asked questions about AAX Biotech AB

What does AAX Biotech AB do?

AAX Biotech AB is a biotech company spun out from Karolinska Institutet by co-founders Mats AA Persson and Daniel X Johansson. We specialize in next-generation antibody therapeutics through our two unique and proprietary technologies, Seqitope™ and Opti-mAb™, that enable high-resolution and high throughput epitope mapping as well as stabilization of single chain variable fragments (scFv) for applications such as bispecific antibodies and CAR-T cells. Our team is made up of highly qualified experts, all with PhDs in relevant fields. Our mission is to innovate and solve unmet needs in antibody-based medicine development. We aim to be a leading partner for the global biopharmaceutical industry focusing on a broad range of diseases including cancer, autoimmune disorders, and neurological conditions. We are committed to providing unparalleled expertise and innovative technologies that contribute to the advancement of novel antibody therapeutics. Technologies: Seqitope™ is a high-resolution, high throughput method for antibody epitope mapping that accelerates the development of efficacious therapeutics. Opti-mAb™ is a new scFv format with dramatically improved expression levels and reduced aggregation tendencies. This will significantly improve the next generation of cutting-edge immunotherapies such as CAR-T and bispecific antibodies.

How many employees does AAX Biotech AB have?

AAX Biotech AB has around 11 employees on LinkedIn.

Where is AAX Biotech AB headquartered?

AAX Biotech AB is headquartered in Stockholm, Stockholm County.

Build a lead list from companies like AAX Biotech AB

Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.